AstraZeneca PLC is 238.6x more valuable than Avalyn Pharma Inc. by market capitalization ($286.27 B vs $1.20 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AVLN | AZN |
|---|---|---|
| Market cap | $1.20 B | $286.27 B |
| US-listed rank | #2504 | #45 |
| SEC filings | 51 | 1,004 |
AstraZeneca PLC is 238.6x more valuable than Avalyn Pharma Inc. by market capitalization ($286.27 B vs $1.20 B).
Full pages: Avalyn Pharma Inc. and AstraZeneca PLC, or browse the full rankings.